Optimi Health Corp.’s (NASDAQ:OPTH) Lock-Up Period Set To End on November 16th

Optimi Health’s (NASDAQ:OPTH) lock-up period will expire on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its IPO on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. After the expiration of Optimi Health’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Weiss Ratings upgraded Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, August 27th. Wall Street Zen upgraded Optimi Health to a “hold” rating in a research note on Saturday, July 25th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Optimi Health has a consensus rating of “Reduce”.

Optimi Health Stock Performance

Shares of OPTH stock opened at $2.26 on Wednesday. Optimi Health has a fifty-two week low of $1.90 and a fifty-two week high of $6.40. The firm has a fifty day moving average price of $3.88. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.06 and a quick ratio of 0.03.

Optimi Health Company Profile

Optimi Health Corp. is a Canadian psychedelics and mental-health company focused on the development, production and distribution of naturally derived psilocybin products and functional mushroom formulations. Its work is directed toward supporting emerging psychedelic-assisted therapies, research and wellness applications. The company operates a Health Canada-licensed manufacturing facility in Princeton, British Columbia, where it cultivates and processes mushrooms and develops products under regulated quality and production standards.